Unichem Labs gets USFDA nod to market generic version of Otezla; stock ends 5 per cent higher
Unichem Labs gets USFDA nod to market generic version of Otezla; stock ends 5 per cent higher

Unichem Labs gets USFDA nod to market generic version of Otezla; stock ends 5 per cent higher

DSIJ Intelligence Article rating: 5.0

Unichem Laboratories Ltd, an international, integrated, speciality pharmaceutical company informed the exchanges on Friday that it has received ANDA approval for its Apremilast tablets in the strengths of 10 mg, 20 mg & 30 mg by United States Food & Drug Administration (USFDA).  

Bears dominate Sensex & Nifty; Tejas Networks gains 9 per cent, KRBL jumps 8 per cent, ONGC slips, PSU Bank index sheds 5 per cent
Bears dominate Sensex & Nifty; Tejas Networks gains 9 per cent, KRBL jumps 8 per cent, ONGC slips, PSU Bank index sheds 5 per cent

Bears dominate Sensex & Nifty; Tejas Networks gains 9 per cent, KRBL jumps 8 per cent, ONGC slips, PSU Bank index sheds 5 per cent

DSIJ Intelligence Article rating: 3.8

On Friday as well, the markets indicated bearish investor sentiments as Sensex ends below 51,000, declining by 434.93 points or 0.85 per cent to settle at 50,889.76 levels while Nifty fell by 137.20 points or 0.91 per cent to close at 14,981.75 levels.   

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 3.7

The market opened in red on February 19, 2021, overall volumes in futures & options currently stand at 8,17,16,388 contracts with a turnover of Rs. 80,21,078.07 crore.

Indian & global macroeconomic weekly
Indian & global macroeconomic weekly

Indian & global macroeconomic weekly

DSIJ Intelligence Article rating: 5.0

In the local economic news, even as the overall consumer inflation for January eased to a 16-month low of 4.09 per cent in January from 4.59 per cent in December, core inflation (a better measure of medium-term inflation), which excludes the effects of volatile food and fuel prices,

RSS
First26202621262226232625262726282629Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR